ITRM20060237A1 - Uso dei probiotici nella prevenzione e nel trattamento delle congiuntiviti allergiche - Google Patents

Uso dei probiotici nella prevenzione e nel trattamento delle congiuntiviti allergiche

Info

Publication number
ITRM20060237A1
ITRM20060237A1 IT000237A ITRM20060237A ITRM20060237A1 IT RM20060237 A1 ITRM20060237 A1 IT RM20060237A1 IT 000237 A IT000237 A IT 000237A IT RM20060237 A ITRM20060237 A IT RM20060237A IT RM20060237 A1 ITRM20060237 A1 IT RM20060237A1
Authority
IT
Italy
Prior art keywords
allergic
probiotics
prevention
treatment
conjunctivitis
Prior art date
Application number
IT000237A
Other languages
English (en)
Inventor
Sergio Bonini
Stefano Bonini
Alessandro Lambiase
Original Assignee
Anabasis S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anabasis S R L filed Critical Anabasis S R L
Priority to IT000237A priority Critical patent/ITRM20060237A1/it
Priority to PCT/IT2007/000327 priority patent/WO2007125566A2/en
Publication of ITRM20060237A1 publication Critical patent/ITRM20060237A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IT000237A 2006-05-03 2006-05-03 Uso dei probiotici nella prevenzione e nel trattamento delle congiuntiviti allergiche ITRM20060237A1 (it)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IT000237A ITRM20060237A1 (it) 2006-05-03 2006-05-03 Uso dei probiotici nella prevenzione e nel trattamento delle congiuntiviti allergiche
PCT/IT2007/000327 WO2007125566A2 (en) 2006-05-03 2007-05-03 Use of probiotics in the prevention and treatment of allergic conjunctivitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000237A ITRM20060237A1 (it) 2006-05-03 2006-05-03 Uso dei probiotici nella prevenzione e nel trattamento delle congiuntiviti allergiche

Publications (1)

Publication Number Publication Date
ITRM20060237A1 true ITRM20060237A1 (it) 2007-11-04

Family

ID=38526725

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000237A ITRM20060237A1 (it) 2006-05-03 2006-05-03 Uso dei probiotici nella prevenzione e nel trattamento delle congiuntiviti allergiche

Country Status (2)

Country Link
IT (1) ITRM20060237A1 (it)
WO (1) WO2007125566A2 (it)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9232663B2 (en) 2011-09-06 2016-01-05 Koninklijke Philips N.V. Method and device of a LED matrix
WO2013130773A2 (en) 2012-02-29 2013-09-06 Ethicon Endo-Surgery, Inc. Compositions of microbiota and methods related thereto
ITRM20120200A1 (it) * 2012-05-09 2013-11-10 Medivis S R L Composizioni oftalmiche topiche a base di probiotici stabilizzati.
WO2014174039A1 (en) * 2013-04-24 2014-10-30 Medizinische Universität Wien Novel vaccine formulation for ocular immunization
SG11201703395PA (en) 2014-10-31 2017-05-30 Whole Biome Inc Methods and compositions relating to microbial treatment and diagnosis of disorders
IT201600081929A1 (it) * 2016-08-03 2018-02-03 St Europeo Di Oncologia S R L Uso del surnatante di lactobacillus paracasei nel trattamento della congiuntivite, in particolare della vernal cheratocongiuntivite
CN111372596A (zh) 2017-08-30 2020-07-03 潘德勒姆治疗公司 用于治疗微生物组相关病症的方法和组合物
CN113164526A (zh) 2018-07-19 2021-07-23 潘德勒姆治疗公司 用于微生物植入的方法和组合物
JP2020162479A (ja) * 2019-03-29 2020-10-08 株式会社キティー 目の不調を改善する組成物及びその利用
JP7701813B2 (ja) * 2021-06-30 2025-07-02 アニコム ホールディングス株式会社 疾患罹患予測システム、保険料算出システム、疾患罹患予測方法及び保険料算出方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002341384A1 (en) * 2001-09-05 2003-03-24 Actial Farmaceutica, Lda. Lactic acid bacteria comprising unmethylated cytosine-guanine dinucleotides for use in therapy
US6994848B2 (en) * 2004-03-25 2006-02-07 Genmont Biotech Inc. Lactobacillus paracasei strain GM-080 for treating allergy related diseases
JP2007084533A (ja) * 2005-08-24 2007-04-05 Prima Meat Packers Ltd 免疫応答調節組成物及び該組成物を有効成分とする食品

Also Published As

Publication number Publication date
WO2007125566A3 (en) 2008-03-13
WO2007125566A2 (en) 2007-11-08

Similar Documents

Publication Publication Date Title
WO2007125566A3 (en) Use of probiotics in the prevention and treatment of allergic conjunctivitis
GEP20094781B (en) Sulfonamide derivatives for the treatment of diseases
WO2004071529A3 (en) Uses of anti-insulin-like growth factor i receptor antibodies
CA3094580C (en) Oral formulations of cytidine analogs and methods of use thereof
EP2526933A3 (en) Inhibitors of bruton's tyrosine kinase
WO2008029276A3 (en) Compositions and methods for the treatment of ophthalmic disease
PL1986669T3 (pl) Zastosowanie Bifidobacterium longum do zapobiegania i leczenia zapalenia
WO2008061226A3 (en) Sustained-release formulations of topiramate
TW200612971A (en) Method for preventing or treating respiratory infections and acute otitis media in infants
WO2009046377A3 (en) Compositions and methods of stem cell therapy for autism
WO2009086457A3 (en) 6,9-disubstituted purine derivatives and their use as cosmetics and cosmetic compositions
EP3050876A3 (en) Kinase modulators
WO2007092550A3 (en) Corneal onlays and related methods
AU2002233288A1 (en) Combined use of Enzyme Inhibitors and Pharmaceutical Preparations thereof for the Treatment and Prophylaxis of Arteriosclerosis, for the Treatment and Prevention of Allergic Reactions of Type I According to the Gell and Coombs Classification, and for the Treatment and Prevention of Dermatological Diseases Associated with FO
ATE535257T1 (de) Ophthalmologische formulierung mit methylsulfonylmethan und ciprofloxacin
MX2021010058A (es) Formulaciones de rapamicina tópicas y su uso en el tratamiento de angiofibromas faciales y otros trastornos de la piel.
AU2021322255A8 (en) Use of dexpramipexole for the treatment of moderate to severe asthma
WO2006116221A3 (en) Therapeutic combinations for the treatment or prevention of psychotic disorders
TW200800977A (en) A new salt
PT1796702E (pt) Utilização de óleo de lavanda para profilaxia e tratamento de distúrbios de somatização e da doença de stress pós-traumático
EA200801890A1 (ru) Средство для лечения шума в ушах
BRPI0811223A2 (pt) Métodos para modular uma inflamação em um paciente, e para tratar, controlar, reduzir ou melhorar uma infecção ocular ou oftálmica e uma sequela inflamatória da mesma, uso de uma fluoroquinolona, e, composição farmacêutica.
CA3241657A1 (en) 4-phenyl-tetrahydropyridine derivatives for treating hearing diseases
WO2006131651A3 (fr) Composition a base d'une avermectine et d’ηydrocortisone notamment pour le traitement de la rosacée
WO2004006887A3 (en) Composition and methods for the treatment of skin disorders